Beijing QL Biopharmaceutical Co., Ltd.
Clinical trials sponsored by Beijing QL Biopharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Kidney patients get first look at new obesity drug Results expected Dec 2026 (estimated)
- New obesity drug ZT002 tested for safety with other medications Results expected Dec 2026 (estimated)
- New Weight-Loss pill ZT006 enters Mid-Stage trial Results expected Dec 2026 (estimated)
- New drug ZT003 tested for safety in first human trial Results expected Dec 2026 (estimated)
- Heart safety check for new Weight-Loss drug candidate Results expected Jan 2027 (estimated)
-
New Weight-Loss drug ZT002 enters early human testing
Disease control CompletedThis early-stage trial tested the safety and tolerability of ZT002, an injectable drug for weight loss, in 28 adults with overweight or obesity. Participants received multiple doses of ZT002 or a placebo to see how the body processes the drug and if any side effects occur. The st…
Phase 1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New weight loss pill ZT006 enters first human tests
Disease control CompletedThis early-stage trial tested ZT006, an experimental daily pill for weight loss, in 94 healthy, overweight, and obese adults. The study checked safety, how the body processes the drug, and the effect of food on absorption. Participants received single or multiple doses, with some…
Phase 1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New Weight-Loss shot shows promise in Mid-Stage trial
Disease control CompletedThis study tested an experimental injection called ZT002 in 303 adults who were overweight or obese. Participants received either the drug or a placebo for 24 weeks. The main goal was to see how much weight they lost and whether they achieved 5%, 10%, or 15% weight loss. The tria…
Phase 2 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC